• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACS¿ LYSE WASH ASSISTANT; STATION, PIPETTING DILUTING CLINICAL USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACS¿ LYSE WASH ASSISTANT; STATION, PIPETTING DILUTING CLINICAL USE Back to Search Results
Catalog Number 337146
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/30/2023
Event Type  malfunction  
Event Description
It was reported that carryover was observed on patient samples during use with the bd facs¿ lyse wash assistant.The following information was provided by the initial reporter: 1.Was there any carryover of patient samples? yes, this was reported by the customer and the reason for the pirs, but for the moment it is unclear if it is related to lwa, bd facslyric or preparation / internal reagent contamination.2.Was there any contamination of patient samples? no if this is a different question to question 3 (if contamination doesn´t mean detected carried over cells).3.Are there erroneous results on patient samples for diagnostic test? can be answered with ¿no¿ because they noticed it during their standard plausibility checks.4.Was there any delay of treatment due to the issue? no.5.If patient samples were redrawn, was there any change or delay of treatment? no.6.Was there any physical harm/injury to the patient due to the issue? no.7.What is the current medical status? n.A.The sample is not separated, the blood is dark red.
 
Manufacturer Narrative
D.4.Medical device expiration date: na.E.1.Initial reporter phone#: (b)(6).H.3.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that carryover was observed on patient samples during use with the bd facs¿ lyse wash assistant.The following information was provided by the initial reporter: 1.Was there any carryover of patient samples? yes, this was reported by the customer and the reason for the pirs, but for the moment it is unclear if it is related to lwa, bd facslyric or preparation / internal reagent contamination.2.Was there any contamination of patient samples? no if this is a different question to question 3 (if contamination doesn´t mean detected carried over cells) 3.Are there erroneous results on patient samples for diagnostic test? can be answered with ¿no¿ because they noticed it during their standard plausibility checks 4.Was there any delay of treatment due to the issue? no.5.If patient samples were redrawn, was there any change or delay of treatment? no.6.Was there any physical harm/injury to the patient due to the issue? no.7.What is the current medical status? n.A.The sample is not separated, the blood is dark red.
 
Manufacturer Narrative
The following fields have been updated with corrected information: g.1 - reporting office contact - fahmy razak.G.1 - manufacturing site contact - fahmy razak.G.1 - reporting office- becton dickinson and company bd biosciences h6.Investigation summary: based on the investigation results, the reported issue of the sample is not separated was not confirmed.Investigation results that were performed on the indicated failure mode were the following: the potential cause was undetermined as the customer resolved the issue on their own and a field service dispatch was not needed.No one was harmed or injured, and no patients were diagnosed or treated based on any erroneous results.The safety risk of this hazard has been identified to be within the acceptable level.The manufacturing device history record (dhr) was reviewed and the instrument met all the manufacturing specifications prior to release.Complaints received for this device will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the collected data for identification of emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD FACS¿ LYSE WASH ASSISTANT
Type of Device
STATION, PIPETTING DILUTING CLINICAL USE
Manufacturer (Section D)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
Manufacturer (Section G)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
Manufacturer Contact
fahmy razak - mdr
2350 qume drive
san jose, CA 95131
4089542435
MDR Report Key17745959
MDR Text Key324034012
Report Number2916837-2023-00180
Device Sequence Number1
Product Code JQW
UDI-Device Identifier00382903371464
UDI-Public00382903371464
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/18/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number337146
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/30/2023
Initial Date FDA Received09/14/2023
Supplement Dates Manufacturer Received03/18/2024
Supplement Dates FDA Received03/19/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/12/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-